KMT2B drives inflammation in endothelial cells and promotes atherosclerosis via histone H3 lysine 4 trimethylation-mediated autophagy
Cardiovascular Research · 2026
DOI: 10.1093/cvr/cvag142 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Research, 2026. Verfasst von Fuyuan Zhang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Drug Discovery from Natural Resources and Industrialization, School of Pharmacy, Macau University of Science and Technology, Taipa, Mac…. Hauptthemen laut MEDLINE: Autophagy, Atherosclerosis, Endothelial Cells, Histone-Lysine N-Methyltransferase. Die Arbeit nennt 49 Literaturangaben. Gefördert von: Macau Science and Technology Development Fund, Shenzhen-Hong Kong-Macao Science and Technology Fund, National Natural Science Foundation of China.
Abstract (Originalsprache)
Aims
Atherosclerosis is a chronic condition characterized by persistent inflammation and vascular remodeling. Oxidized low-density lipoprotein (ox-LDL) plays a central role in this process by promoting inflammation and inducing epigenetic modifications. This study aimed to investigate the role of KMT2B, a histone methyltransferase, in regulating inflammation and autophagy in endothelial cells (ECs) during atherosclerosis. Methods and results ApoE−/− mice were fed a western diet for 2, 4, 8, and 12 weeks to assess epigenetic modifications during atherosclerosis. In vitro, rat aortic endothelial cells (RAECs) and human aortic endothelial cells (HAECs) were exposed to ox-LDL at various time points. To study the role of KMT2B in inflammation, small-interfering RNA-mediated knockdown and plasmid overexpression were employed to manipulate KMT2B expression in RAECs and HAECs. In vivo, Kmt2b was knocked down using lentivirus-expressed sgKmt2b in ApoE−/− mice, and its impact on atherosclerotic plaque formation, lipid accumulation, and inflammatory cytokines was evaluated. To explore the mechanism by which ox-LDL regulates the expression of KMT2B, reactive oxygen species (ROS) levels were detected, and siSyk and siFos were performed in RAECs. Western diet feeding of ApoE−/− mice resulted in elevated KMT2B expression and H3K4me3 levels in atherosclerotic plaques, particularly in ECs and macrophages. KMT2B was found to directly regulate autophagy, followed by the regulation of inflammation. Furthermore, inhibiting the expression of KMT2B in ApoE−/− mice improved atherosclerosis and suppressed inflammation. The transcription factor Fos mediated KMT2B expression through Syk- and ROS-dependent signaling, enhancing its binding to the Kmt2b promoter region.
Conclusion
KMT2B is a critical regulator of autophagy and inflammation in atherosclerosis, with Fos-mediated signaling driving its expression. Targeting KMT2B may offer a promising therapeutic strategy for modulating inflammation and plaque progression in atherosclerosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Drug Discovery from Natural Resources and Industrialization, School of Pharmacy, Macau University of Science and Technology, Taipa, Macau 999078, China.
- Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliat…
- Nutrilite Health Institute, Shanghai Innovation Center, Shanghai 201203, China.
- Department of Pharmacology, Shanghai Key Laboratory of Bioactive Small Molecules, School of Pharmacy, Fudan University, 826 Zhangheng Road, Pudong New Area, Shanghai 201203, China.
- Department of Cardiology, Zhuhai People's Hospital, Zhuhai Hospital Affiliated with Jinan University, No. 79 Kangning Road, Xiangzhou District, Zhuhai, Guangdong 519000, China.
ORCID-Profile: Yi Zhun Zhu
Förderung
- Macau Science and Technology Development Fund
- Shenzhen-Hong Kong-Macao Science and Technology Fund
- National Natural Science Foundation of China
- Amway (China) Fund
Zitieren
APA
Zhang, F., Fu, R., Lin, Z., Hu, Q., Zheng, D., Zhang, H., Huang, Y., Zhu, M., Lu, L., Shu, W., Li, Y., Kan, J., Ding, Q., & Zhu, Y. Z. (2026). KMT2B drives inflammation in endothelial cells and promotes atherosclerosis via histone H3 lysine 4 trimethylation-mediated autophagy. Cardiovascular Research. https://doi.org/10.1093/cvr/cvag142
Vancouver
Zhang F, Fu R, Lin Z, Hu Q, Zheng D, Zhang H, et al. KMT2B drives inflammation in endothelial cells and promotes atherosclerosis via histone H3 lysine 4 trimethylation-mediated autophagy. Cardiovascular Research. 2026. doi:10.1093/cvr/cvag142
BibTeX
@article{Zhang2026,
author = {Zhang, Fuyuan and Fu, Rong and Lin, Zhongxiao and Hu, Qingwen and Zheng, Dechong and Zhang, Hao and Huang, Yu and Zhu, Menglin and Lu, Liuyi and Shu, Wen and Li, Yibo and Kan, Juntao and Ding, Qian and Zhu, Yi Zhun},
title = {KMT2B drives inflammation in endothelial cells and promotes atherosclerosis via histone H3 lysine 4 trimethylation-mediated autophagy},
journal = {Cardiovascular Research},
year = {2026},
doi = {10.1093/cvr/cvag142}
}
EUVIMED